NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 870 filers reported holding NOVARTIS A G in Q1 2016. The put-call ratio across all filers is 0.75 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $451,000 | +65.8% | 5,237 | +45.6% | 0.61% | +39.6% |
| Q2 2018 | $272,000 | -88.5% | 3,596 | -87.0% | 0.43% | -36.1% |
| Q3 2017 | $2,367,000 | -83.1% | 27,571 | -83.6% | 0.68% | -78.5% |
| Q2 2017 | $13,997,000 | +359.1% | 167,686 | +298.4% | 3.16% | +177.6% |
| Q1 2016 | $3,049,000 | +438.7% | 42,088 | +539.3% | 1.14% | +319.9% |
| Q4 2015 | $566,000 | +64.1% | 6,583 | +75.4% | 0.27% | +185.3% |
| Q3 2015 | $345,000 | -40.9% | 3,754 | -36.8% | 0.10% | -36.2% |
| Q2 2015 | $584,000 | +15.9% | 5,942 | +16.4% | 0.15% | -17.7% |
| Q1 2015 | $504,000 | -59.7% | 5,107 | -63.0% | 0.18% | -48.6% |
| Q2 2014 | $1,251,000 | +27.8% | 13,816 | +8.3% | 0.35% | +61.5% |
| Q3 2013 | $979,000 | +44.2% | 12,756 | +32.9% | 0.22% | +22.5% |
| Q2 2013 | $679,000 | – | 9,600 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |